Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma-Reference-Cited by-同舟云学术

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma

Published:2017-07-17 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Bjørklund Sunniva Stordal,Panda Anshuman,Kumar Surendra,Seiler Michael,Robinson Doug,Gheeya Jinesh,Yao Ming,Alnæs Grethe I. Grenaker,Toppmeyer Deborah,Riis Margit,Naume Bjørn,Børresen-Dale Anne-Lise,Kristensen Vessela N.,Ganesan Shridar,Bhanot Gyan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-05537-0.pdf

Reference66 articles.

1. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752, doi: 10.1038/35021093 (2000).

2. Sørlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98, 10869–10874, doi: 10.1073/pnas.191367098 (2001).

3. Wang, Y. et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671–679, doi: 10.1016/S0140-6736(05)17947-1 (2005).

4. Alexe, G. et al. High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. Cancer Res 67, 10669–10676, doi: 10.1158/0008-5472.CAN-07-0539 (2007).

5. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352, doi: 10.1038/nature10983 (2012).

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a novel alternative splicing isoform of the Hippo kinase STK3/MST2 with impaired kinase and cell growth suppressing activities;Oncogene;2024-08-22

2. Subtype-specific alternative splicing events in breast cancer identified by large-scale data analysis;Scientific Reports;2024-06-19

3. Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia;Molecular Therapy - Nucleic Acids;2024-06

4. Expression of Truncated Products at the 5′-Terminal Region of RIPK2 and Evolutive Aspects that Support Their Biological Importance;Genome Biology and Evolution;2024-05-16

5. Subtype-specific alternative splicing events in breast cancer identified by large-scale data analysis;2024-04-10